We have an exciting opportunity for a Postdoctoral Researcher to join Professor Kate Vallis’s group investigating the development of novel agents for (1) radionuclide imaging and (2) molecularly targeted radionuclide therapy. Other major themes are the dosimetry of radionuclide-based agents in cancer medicine and image-guided radiation therapy (IGRT).You will work as part of a multidisciplinary team of scientists who are developing agents directed against cancer targets including DNA damage signalling proteins and cancer cell surface receptors. Current studies are in breast, lung and oesophageal cancers but are relevant to many common cancers that collectively represent a major UK public health problem.You will hold or will be working towards a PhD or equivalent in medical physics, nuclear medicine, nuclear physics, imaging or a related field and will have experience of working with radionuclide dosimetry/microdosimetry.This is a full-time post and is offered for 2 years in the first instance with the possibility to extend to 3 years.All applicants must complete an application form and upload a CV and supporting statement.The closing date for applications is 12.00 noon on 9 January 2017.
Postdoctoral Researcher - Nuclear Medicine Dosimetry
Monday, January 9, 2017 - 12:00
CRUK/MRC Oxford Institute for Radiation and Oncology
We aim to enhance clinical and basic cancer research in Oxford with the ultimate goal of increasing cancer cure rates.
In Oxford, we have a great wealth of broad-ranging expertise and a powerful network of cancer researchers.
Study With Us
Our graduate training programmes for both scientists and clinicians are internationally recognised.